InvestorsHub Logo
Followers 1
Posts 90
Boards Moderated 0
Alias Born 03/22/2016

Re: None

Thursday, 11/19/2020 11:39:16 AM

Thursday, November 19, 2020 11:39:16 AM

Post# of 6390
Great, they have started Phase 1 of BP 2001. The web site says:

BP1002 (Liposomal Bcl2 Antisense)

Bio-Path is planning to initiate a Phase 1 clinical trial of BP1002 in patients with follicular lymphoma, the most common form of non-Hodgkin’s lymphoma (NHL) in 2017.

so they are only 3 3/4 years behind schedule. Meanwhile PN is taking a huge salary drawing down the limited funds.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News